(19)
(11) EP 4 429 673 A1

(12)

(43) Date of publication:
18.09.2024 Bulletin 2024/38

(21) Application number: 22893836.1

(22) Date of filing: 10.11.2022
(51) International Patent Classification (IPC): 
A61K 31/7008(2006.01)
A61K 31/7016(2006.01)
A61K 31/7028(2006.01)
A61P 31/02(2006.01)
A61K 31/70(2006.01)
A61K 31/7024(2006.01)
A61P 9/02(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 9/02; A61K 31/7034; A61K 31/7056; A61K 31/704; A61K 31/706; A61K 31/702
(86) International application number:
PCT/US2022/079624
(87) International publication number:
WO 2023/086877 (19.05.2023 Gazette 2023/20)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 12.11.2021 US 202117525060

(71) Applicant: Ayuvis Research, Inc.
Fort Worth, TX 76107 (US)

(72) Inventors:
  • ACHARYA, Suchismita
    Grapevine, TX 76051 (US)
  • BEHERA, Sumita
    Flower Mound, TX 75022 (US)

(74) Representative: Müller-Boré & Partner Patentanwälte PartG mbB 
Friedenheimer Brücke 21
80639 München
80639 München (DE)

   


(54) NOVEL COMPOSITIONS AND THERAPEUTIC METHODS